iLawà prototypes are designed to be easily carried in small fishing boats. (Photo from DOST-PCIEERD)
The DOST-PCIEERD said the “durable, cost-effective” battery technology was developed by researchers from the Technological Institute of the Philippines (TIP).
“Dubbed iLAWA, derived from the Filipino phrase ilaw mula sa lawa (light from the lake), the researchers developed the battery technology from recycled aluminum like cans to help light the path of fisherfolks and clean lakes when submerged underwater,” it said in a statement.
The Council noted that the TIP’s battery gets its power from the electrolytes in the water due to the presence of electric charges.
MANILA, May 3 Aiming to upskill science researchers on publishing their work, the Department of Science and Technology Philippine Council for Industry, Energy and Emerging Technology Research and Development and global scientific publication aggregator Elsevier trained 4,000 scientists and engineers from 26 countries on using the scientific search engine.
Entitled “Best Practices in Writing and Publishing Your Research Paper,” the webinar is a first of a series of workshops lined up for the renewed partnership between the DOST council and Elsevier in boosting the capabilities of the country’s science and technology (S&T) community.
The event was facilitated by Johan Jang, customer consultant of Elsevier Southeast Asia.
Results of ivermectin clinical trial out by Q1 2022
enablePagination: false
endIndex:
Metro Manila (CNN Philippines, May 3) The planned clinical trial of the antiparasitic drug ivermectin for treatment of mild COVID-19 may be completed by early 2022, a government official said Monday.
Dr. Jaime Montoya, chief of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD), said that while the clinical trial itself may be concluded before the end of the year, the research team still needs to examine all the information collected during the study. Pag-aaralan pa ang mga datos. Ito ay malamang lalabas sa first quarter of next year, mga January, he said in a virtual briefing.
To all Filipino researchers, it’s your time to shine.
The Department of Science and Technology Philippine Council for Industry, Energy and Emerging Technology Research and Development (DOST-PCIEERD) has started accepting Monday, May 3, research and development (R&D)/science and technology (S&a
Philippine Red Cross Isolation Facility (Photo from PRC)
This was bared by Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) Executive Director Dr. Jaime C. Montoya during a televised public briefing on Monday, May 3.
“Tinitingnan na po natin ngayon ay mga quarantine facilities ng Philippine Red Cross, kasama po natin sila sa pagaaral na isasagawa (We are looking at the quarantine facilities of the Philippine Red Cross, they are with us in the study that will be conducted),” he said.
He clarified that the participation of the coronavirus disease (COVID-19) patients with mild to moderate cases in the clinical trial is “voluntary”.